PTGS2 and chronic myelogenous leukemia, BCR-ABL1 positive: In chronic myeloid leukemia (CML), HMGB1 knockdown can arrest the cell cycle at the G1 phase and inhibit cell proliferation by downregulating the expression of cyclooxygenase-2 (COX-2) [115].